Attention deficit hyperactivity disorder associated with one variant of the dopamine receptor gene may have a better clinical outcome than other types
Attention deficit hyperactivity disorder (ADHD) associated
with one variant of the dopamine receptor gene may have a better clinical outcome
than other types, according to an article in the August issue of Archives of General
Psychiatry.
The imaging study also found that the same genotype was
associated with thinner tissue in brain regions that handle attention, the right
orbitofrontal/inferior prefrontal and posterior parietal cortex.
ADHD is among the most heritable of neuropsychiatric
disorders, according to background information in the article. Several genes have
been identified as possibly associated with the condition. One of the most frequently
cited is a polymorphism of the dopamine D4 receptor gene (DRD4) known as the 7-repeat
form.
“Previous studies have suggested that carriers of the
risk allele may also have a unique neuropsychological, clinical and pharmacological
profile, although there remains considerable debate over the exact nature of this
phenotype,” the authors wrote.
In the current work, Philip Shaw, MD, PhD, of the National
Institute of Mental Health, Bethesda, MD, and colleagues compared 105 children
with the disorder (average, 10.1 years) to 103 healthy controls, using both magnetic
resonance imaging and DNA testing. Sixty-seven (64 percent) of the children with
the disorder also had a follow-up clinical evaluation an average of six years
later.
Among all participants, both with and without the disorder,
having the 7-repeat form of DRD4 was associated with thinner tissue in the right
orbitofrontal/inferior prefrontal and posterior parietal cortex. Similar regions
were also generally thinner in participants with ADHD than those without.
“As a result of the overlapping main effects of genotype
and diagnosis, there was a stepwise increment in cortical thickness in these regions,
with subjects with ADHD with the DRD4 7-repeat allele having the thinnest cortex,
followed by subjects with ADHD lacking the 7-repeat allele, healthy 7-repeat allele
carriers and finally by healthy non-carriers,” the authors wrote.
Analyses of the children who participated in the follow-up
revealed that the differences between brain anatomy of those with and without
the DRD4 7-repeat allele were most pronounced in early development and disappeared
by late adolescence. Individuals with ADHD who carried the DRD4 7-repeat allele
had better clinical outcomes and regained thickness in their right parietal cortex-a
sign previously linked to better outcomes and that parallels ADHD’s natural history
of improvement with age.
“Cross-sectional studies have found regional increases
in cortical thickness to correlate with cognitive function, including enhanced
verbal declarative and extinction memory, and with ‘fluid’ intelligence in older,
healthy subjects,” the authors wrote. “In children, gains in verbal knowledge
are mirrored by change in the cortical thickness of speech areas. While our current
study demonstrates changes in cortical thickness and symptoms occurring in tandem,
a future goal is to refine further our appreciation of cortical thickness by examining
the links between this neuroanatomical variable and putative cognitive endophenotypes
for ADHD, such as response inhibition and working memory.”
|